1
Clinical Trials associated with MSC Secretome Eye Drops(University of Illinois) / CompletedEarly Phase 1IIT Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
This study is a longitudinal assessment using a classic dose-escalation study design to assess the safety and maximal tolerated dose (MTD) of topical MSC Secretome eye drops. The study will be conducted at Illinois Eye and Ear Infirmary located at University of Illinois at Chicago. The study will use anterior segment Optical Coherence Tomography (OCT)/Scheimpflug Imaging, esthesiometry, and visual analogue scale (VAS) to assess treatment tolerability.
100 Clinical Results associated with MSC Secretome Eye Drops(University of Illinois)
100 Translational Medicine associated with MSC Secretome Eye Drops(University of Illinois)
100 Patents (Medical) associated with MSC Secretome Eye Drops(University of Illinois)
100 Deals associated with MSC Secretome Eye Drops(University of Illinois)